5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses.

Autor: Nikolayeva, Y. V., Ulashchik, E. A., Chekerda, E. V., Galochkina, A. V., Slesarchuk, N. A., Chistov, A. A., Nikitin, T. D., Korshun, V. A., Shmanai, V. V., Ustinov, A. V., Shtro, A. A.

Publikováno v: Russian Journal of Bioorganic Chemistry; May2020, Vol. 46 Issue 3, p315-320, 6p

Phenotypic assessment of antiviral activity for spiro-annulated oxepanes and azepenes.

Autor: Osolodkin DI; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia.; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Kozlovskaya LI; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia., Iusupov IR; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Kurkin AV; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Shustova EY; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Orlov AA; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Khvatov EV; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Mutnykh ES; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Kurashova SS; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Vetrova AN; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Yatsenko DO; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Goryashchenko AS; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Ivanov VN; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Lukyanenko ER; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia., Karpova EV; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Stepanova DA; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Volok VP; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Sotskova SE; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Dzagurova TK; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Karganova GG; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia., Lukashev AN; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia., Ishmukhametov AA; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia.

Publikováno v: Chemical biology & drug design [Chem Biol Drug Des] 2024 May; Vol. 103 (5), pp. e14553.

Coronaviruses and Other Novel Antiviral Targets

Autor: Katherine Seley-Radtke

Annual Reports in Medicinal Chemistry, Volume 57 in this long-running series, highlights new advances in the field with this new volume presenting interesting chapters on the Mechanism of action of the broadly acting antiviral drug remdesivir, Improv